Targeted therapies: Tyrosine-kinase inhibitors--new standard for NSCLC therapy (Q42845478)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 1, 2010

Language	Label	Description	Also known as
English	Targeted therapies: Tyrosine-kinase inhibitors--new standard for NSCLC therapy	scientific article published on November 1, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Targeted therapies: Tyrosine-kinase inhibitors--new standard for NSCLC therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Nagahiro Saijo

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Nature Reviews Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

618-619

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.168

31 March 2020

Identifiers

10.1038/NRCLINONC.2010.168

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42845478&oldid=2224812361"